GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Notable Labs Ltd (OTCPK:NTBLQ) » Definitions » Long-Term Capital Lease Obligation

NTBLQ (Notable Labs) Long-Term Capital Lease Obligation : $1.25 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Notable Labs Long-Term Capital Lease Obligation?

Notable Labs's Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was $1.25 Mil.

Notable Labs's quarterly Long-Term Capital Lease Obligation declined from Dec. 2023 ($1.53 Mil) to Mar. 2024 ($1.39 Mil) and declined from Mar. 2024 ($1.39 Mil) to Jun. 2024 ($1.25 Mil).

Notable Labs's annual Long-Term Capital Lease Obligation declined from Dec. 2021 ($0.24 Mil) to Dec. 2022 ($0.00 Mil) but then increased from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($1.53 Mil).


Notable Labs Long-Term Capital Lease Obligation Historical Data

The historical data trend for Notable Labs's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Notable Labs Long-Term Capital Lease Obligation Chart

Notable Labs Annual Data
Trend Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
0.24 - 1.53

Notable Labs Quarterly Data
Dec21 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial - - 1.53 1.39 1.25

Notable Labs  (OTCPK:NTBLQ) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Notable Labs Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Notable Labs's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Notable Labs Business Description

Industry
Traded in Other Exchanges
N/A
Address
320 Hatch Drive, Foster City, CA, USA, 94404
Notable Labs Ltd is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), Notable bio-simulates a cancer treatment to predict whether or not a patient is likely to respond to that specific therapeutic. PPMP is designed to enable Notable to identify and select patients expected to be clinically responsive before the initiation of their treatment and potentially enable fast-track therapeutic development in this patient population.